ANTIVIRAL DRUG DEVELOPMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION
$300,000N43FY2020AINIH
Zymeron Corporation, Durham NC
Investigators
Abstract
To develop a therapeutic that will effect a functional cure of chronic hepatitis B.
View original record on NIH RePORTER →